Advances in Chronic Kidney Disease
Volume 14, Issue 2 , Pages 191-198, April 2007

Medications During Pregnancy: Antihypertensives and Immunosuppressives

  • Jason G. Umans

      Affiliations

    • Penn Medical Laboratory, MedStar Research Institute, Washington, DC
    • Department of Medicine, Georgetown University, Washington, DC
    • Department of Obstetrics and Gynecology, Georgetown University, Washington, DC.
    • Corresponding Author InformationAddress correspondence to Jason G. Umans, MD, PhD, 108 Irving Street, NW - Annex 2, Washington, DC 20010-2975.

Use of prescription and nonprescription medications is common during pregnancy and is required in many women with underlying kidney disease or hypertension and in all with solid-organ allografts. Systematic assessment of drug safety during pregnancy is lacking, as are rigorous and comprehensive studies of pharmacokinetics and pharmacodynamics to guide drug selection and dosing across pregnancy. Renal and hepatic clearances of many drugs change markedly during pregnancy and pitfalls may complicate routine therapeutic monitoring of some drugs during pregnancy. However, available data and clinical experience allow reasonable strategies for selection and dosing of immunosuppressive agents in pregnant transplant recipients and of antihypertensive agents in women with mild or more severe hypertension complicating their pregnancies.

Index Words: Hypertension in pregnancy, kidney disease in pregnancy, antihypertensive drugs, pharmacokinetics in pregnancy, drug metabolism in pregnancy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by grants from NICHD (5U10HD047890) and NCRR (1M01RR020359).

PII: S1548-5595(07)00010-9

doi:10.1053/j.ackd.2007.01.009

Advances in Chronic Kidney Disease
Volume 14, Issue 2 , Pages 191-198, April 2007